ArticleInternational ophthalmology2026
The impact of umbilical cord blood platelet lysate on human corneal endothelium during organ culture.
Article in International ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeTo evaluate whether umbilical cord blood platelet lysate (UCB-PL) can preserve the morphology and characteristics of human corneal endothelial cells during organ culture and serve as a xeno-free alternative to fetal bovine serum (FBS).
methodsPaired human donor corneas were cultured for 28 days in α-MEM-based medium supplemented with either 2% FBS or 2% UCB-PL. Endothelial morphology, cell density, viability, and mosaic regularity were assessed at predefined time points. Metabolic activity was evaluated by measuring pH, glucose, and lactate concentrations in the culture media. Endothelial integrity, apoptosis, and proliferation were analyzed by whole-mount immunofluorescence staining for ZO-1, Na⁺/K⁺-ATPase, caspase-3, and Ki-67.
resultsCorneas stored in UCB-PL-supplemented medium demonstrated endothelial morphology, cell density decline, and viability comparable to those observed in FBS-supplemented medium throughout the culture period. No significant differences were detected between groups at any time point. Metabolic analysis showed sustained glucose availability and expected lactate accumulation in both media, without evidence of nutrient depletion. Immunofluorescence confirmed preserved endothelial junctional organization and pump protein expression, with no signs of endothelial apoptosis or proliferation.
conclusionIn this pilot feasibility study, UCB-PL supported preservation of human corneal endothelial morphology and endothelial-associated protein expression during organ culture and demonstrated similar trends to FBS. These findings support further investigation of UCB-PL as a potential xeno-free alternative for corneal storage media.
Indexed as
Identifiers
42525298What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.